U.S. Markets closed

Vivus fell 4.2% to 13.72

Vivus (VVUS) fell 4.2% to 13.72 in heavy volume after Brean Capital downgraded the stock to sell from hold on lowered estimates for sales of its obesity drug Qsymia. Arena Pharmaceuticals (ARNA), which makes rival obesity drug Belviq, closed unchanged.